share_log

Chijet Motor Company, Inc. Announces Receipt of Nasdaq Notice of Deficiency Resulting From Resignation of Director

Chijet Motor Company, Inc. Announces Receipt of Nasdaq Notice of Deficiency Resulting From Resignation of Director

Chijet Motor Company, Inc. 宣佈收到納斯達克關於董事辭職導致的缺陷的通知
GlobeNewswire ·  03/21 16:30

YANTAI, China, March  21, 2024  (GLOBE NEWSWIRE) -- Chijet Motor Company, Inc. (Nasdaq: CJET) (the "Company" or "Chijet"), a high-tech enterprise engaged in the development, manufacture, sales, and service of traditional fuel vehicles and new energy vehicles ("NEV") in China, today announced today announced that it received a deficiency notice (the "Notice") from the Nasdaq Stock Market LLC ("Nasdaq") on March 20, 2024. The deficiency cited by Nasdaq was due to the resignation of Mr. Simon Pang, an independent director of the Company, from the board of directors (the "Board") and the audit committee of the Board (the "Audit Committee"). As a result of the Resignation of Mr. Pang, the Company is no longer in compliance with Nasdaq's audit committee requirements as set forth in Listing Rule 5605. The Notice states that, consistent with Listing Rule 5605(c)(4), Nasdaq will provide the Company a cure period until the earlier of the Company's next annual shareholders' meeting or March 15, 2025, to regain compliance; provided that if the next annual shareholders' meeting is held before September 11, 2024, then the Company must evidence compliance no later than September 11, 2024.

中國煙臺,2024年3月21日(GLOBE NEWSWIRE)——在中國從事傳統燃油汽車和新能源汽車(“新能源汽車”)開發、製造、銷售和服務的高科技企業赤捷汽車有限公司(納斯達克股票代碼:CJET)(“公司” 或 “Chijet”)今天宣佈,它收到了納斯達克股票市場有限責任公司的缺陷通知(“通知”)“納斯達克”)將於2024年3月20日上線。納斯達克列舉的缺陷是由於該公司獨立董事Simon Pang先生辭去董事會(“董事會”)和董事會審計委員會(“審計委員會”)的職務。由於龐先生辭職,該公司不再遵守《上市規則》5605中規定的納斯達克審計委員會的要求。該通知指出,根據上市規則5605(c)(4),納斯達克將爲公司提供補救期,直至公司下一次年度股東大會或2025年3月15日(以較早者爲準),以恢復合規;前提是,如果下一次年度股東大會在2024年9月11日之前舉行,則公司必須在2024年9月11日之前證明合規。

If the Company does not regain compliance by the expiration of the cure period, the Company's securities will be subject to delisting. At that time, the Company may appeal the delisting determination to a Hearings Panel. The Company plans to search for candidates and fill in the vacancy on the Audit Committee within the cure period provided by Nasdaq. The Notice has no immediate impact on the listing of the Company's ordinary shares on Nasdaq.

如果公司在補救期到期前仍未恢復合規,則公司的證券將被退市。屆時,公司可以就除牌決定向聽證小組提出上訴。該公司計劃在納斯達克提供的補救期內尋找候選人並填補審計委員會的空缺。該通知對公司普通股在納斯達克的上市沒有直接影響。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論